Salud financiera de hoja de balance de Eton Pharmaceuticals
Salud financiera controles de criterios 4/6
Eton Pharmaceuticals tiene un patrimonio de los accionistas total de $16.0M y una deuda total de $4.1M, lo que sitúa su ratio deuda-patrimonio en 25.8%. Sus activos y pasivos totales son $35.8M y $19.9M respectivamente.
Información clave
25.8%
Ratio deuda-patrimonio
US$4.13m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$20.26m |
| Patrimonio | US$15.98m |
| Total pasivo | US$19.86m |
| Activos totales | US$35.84m |
Actualizaciones recientes sobre salud financiera
Is Eton Pharmaceuticals (NASDAQ:ETON) A Risky Investment?
Oct 07
Here's Why Eton Pharmaceuticals (NASDAQ:ETON) Can Manage Its Debt Despite Losing Money
Sep 30Is Eton Pharmaceuticals (NASDAQ:ETON) Using Too Much Debt?
Jun 29Is Eton Pharmaceuticals (NASDAQ:ETON) Using Debt In A Risky Way?
Dec 22Eton Pharmaceuticals (NASDAQ:ETON) Is Using Debt Safely
Oct 14Is Eton Pharmaceuticals (NASDAQ:ETON) Using Too Much Debt?
Apr 05Recent updates
Investors Appear Satisfied With Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Prospects As Shares Rocket 29%
Nov 14Is Eton Pharmaceuticals (NASDAQ:ETON) A Risky Investment?
Oct 07After Leaping 26% Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Shares Are Not Flying Under The Radar
Sep 10Subdued Growth No Barrier To Eton Pharmaceuticals, Inc. (NASDAQ:ETON) With Shares Advancing 40%
Jan 09The Consensus EPS Estimates For Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Just Fell A Lot
Dec 13Eton Pharmaceuticals' (NASDAQ:ETON) Earnings May Just Be The Starting Point
Nov 16Here's Why Eton Pharmaceuticals (NASDAQ:ETON) Can Manage Its Debt Despite Losing Money
Sep 30Not Many Are Piling Into Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Stock Yet As It Plummets 26%
Jul 25Is Eton Pharmaceuticals (NASDAQ:ETON) Using Too Much Debt?
Jun 29Is Eton Pharmaceuticals (NASDAQ:ETON) Using Debt In A Risky Way?
Dec 22Eton Pharmaceuticals acquires FDA-approved rare disease product betaine anhydrous
Sep 13Eton Pharmaceuticals: An Evolving 'Sum Of The Parts' Story
Aug 14Eton Pharma jumps 20% on FDA approval of seizure therapy
Jul 18Broker Revenue Forecasts For Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Are Surging Higher
Apr 15Eton Pharmaceuticals (NASDAQ:ETON) Is Using Debt Safely
Oct 14Another Look At Eton Pharmaceuticals
Sep 03What Does The Future Hold For Eton Pharmaceuticals, Inc. (NASDAQ:ETON)? These Analysts Have Been Cutting Their Estimates
Aug 18Eton Pharma wins FDA approval for Rezipres
Jun 15FDA declines to approve Eton Pharmaceuticals' methanol poisoning treatment
May 28Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Is About To Turn The Corner
May 15Is Eton Pharmaceuticals (NASDAQ:ETON) Using Too Much Debt?
Apr 05Could The Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Ownership Structure Tell Us Something Useful?
Mar 01Eton Pharma buys Canadian rights for Alkindi Sprinkle
Jan 14Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Shift From Loss To Profit
Jan 07
Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($29.7M) de ETON superan a sus pasivos a corto plazo ($19.7M).
Pasivo a largo plazo: Los activos a corto plazo de ETON ($29.7M) superan a sus pasivos a largo plazo ($126.0K).
Historial y análisis de deuda-patrimonio
Nivel de deuda: ETON tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de ETON ha crecido de 0% a 25.8% en los últimos 5 años.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: ETON tiene suficiente cash runway para más de 3 años basándose en su flujo de caja libre actual.
Pronóstico de cash runway: Datos insuficientes para determinar si ETON tiene suficiente cash runway en caso de que su flujo de caja libre siga creciendo o disminuyendo basado en tasas históricas.